医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

STRIVE and MACNICA Partner to Use AI to Optimize Performance for Elite Athletes and Teams

2021年08月10日 PM10:00
このエントリーをはてなブックマークに追加


 

BOTHELL, Wash.

STRIVE, the only platform proven to optimize muscle performance for elite athletes and teams, today announced a strategic partnership with MACNICA, a leading Japanese global technology provider. By combining STRIVE’s unique ability to measure muscle movement and activation in athletes with MACNICA’s cutting-edge artificial intelligence (AI) platform, the companies will produce novel insights that empower professional sports teams to compete and win at the highest level. Macnica Networks, a subsidiary of MACNICA, will be in charge of business operations in partnership with STRIVE.

STRIVE uses proprietary algorithms and electromyography (EMG) sensors seamlessly integrated into any compression clothing to measure and monitor the muscle activation of athlete’s hamstrings, glutes and quadriceps. Through this partnership, AI algorithms developed by MACNICA’s AI Research & Innovation Hub will analyze STRIVE muscle performance data to deliver insights that help coaches and trainers to plan optimal training regimens tailored to each athlete’s muscle activity, fatigue level, and injury risk.

“Between its industry-leading AI technologies, deep presence in the Japanese market and tenacious approach towards market expansion, working with MACNICA is a major step forward in expanding STRIVE’s footprint in the global sports industry,” said Nikola Mrvaljevic, CEO and founder of STRIVE. “We look forward to the long-term growth and value to come from this powerful partnership, for both companies.”

“Starting with STRIVE’s solution, Macnica Networks will accelerate the digital transformation in sports with the theme of sports x technology. By discovering and applying the world’s most advanced technology—one of MACNICA’s strengths—we aim to make the technology the standard for professional teams and elite athletes,” said Jun Ikeda, president of Macnica Networks.

Today’s announcement comes on the heels of STRIVE and KINEXON’s strategic partnership and is the latest step the company is taking to optimize the performance of elite athletes and teams. To learn more about STRIVE, please visit: www.strive.tech.

ABOUT MACNICA

Since it was established in 1972, MACNICA has provided leading-edge semiconductors, electronic devices, networks and cyber security products with high value-added technology. More recently, MACNICA has been actively developing new businesses in the fields of AI, IoT, automated driving and robotics, based on its strength in global sourcing and strategic planning for world-leading technologies. With its slogan “Co.Tomorrowing,” MACNICA connects leading-edge technologies with ‘MACNICA’ intelligence to provide unique services and solutions, creating social value and contributing to the betterment of future societies. Headquartered in Yokohama, MACNICA’s global business spans 23 countries and 85 locations worldwide. For more information, please visit https://www.macnica.co.jp/en/.

ABOUT STRIVE

STRIVE delivers the only platform proven to optimize muscle performance for elite athletes and teams. Through proprietary algorithms and sensors that seamlessly integrate into any compression clothing, STRIVE provides the most complete, accurate and actionable data for athletes to always compete at peak performance. Founded in 2016, STRIVE currently works with NCAA, NFL, EPL, and MLS teams, along with the US Military. For more information visit www.strive.tech or follow STRIVE on Twitter, LinkedIn, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210810005164/en/

CONTACT

MEDIA CONTACT

Kelly Mitchell

fama PR for STRIVE

strive@famapr.com

(617) 986-5056

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • DKT International Implements Traditional and New Forms of Marketing in Africa, South America, and Southeast Asia to Expand Access to Contraceptives
  • オルガノンが計画外妊娠をめぐり世界規模の対話の喚起を目指す
  • IHMA Opens Microbiology Reference Laboratory in Shanghai, China to Further Support Global Anti-Infective Product Discovery and Development
  • Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti-cancer Drug Development
  • Takeda Selects Four New Partners for Annual Global Corporate Social Responsibility (CSR) Program to Help Strengthen Health Systems in Low- and Middle-Income Countries